Tizanidine Tablet
Product Images NDC 63629-7037

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63629-7037). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine 1

FDA Label Image

Tizanidine 2

This text provides dosage information for Tizanidine capsules, specifying a dose of 4 mg to be taken with or without food. It also includes a chart indicating the effect of the medication at different time intervals after dosing.*

FDA Label Image

Tizanidine 3

FDA Label Image

Tizanidine 4

This text discusses the improvement in Ashworth Score over the course of a study, with mentions of the mean dose used and specific time points such as the end of titration (Study Week 3) and the end of maintenance (Study Week 7). It also refers to the endpoint using the Last Observation Carried Forward method.*

FDA Label Image

Label Image (Lbl636297037)

This text provides information about a medication called Tizanidine HCL 2mg tablet, packaged by Begane Ranch Bukank. The tablets should be stored at room temperature between 20-25°C (68-77°F) and kept out of reach of children. Each package contains 30 tablets and has an expiration date indicated as MM/YY. The National Drug Code (NDC) for this medication is 6362970371070371103641.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.